ELOXX PHARMACEUTICALS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | $5.0M | $5.8M | $33.2K |
| FY2018 | $7.8M | $50.7M | $48.6M |
| FY2019 | $22.7M | $58.9M | $22.5M |
| FY2020 | $16.2M | $26.5M | $24.7M |
| FY2021 | $22.8M | $45.1M | $42.3M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | $5.0M | $5.8M | $33.2K |
| FY2018 | $7.8M | $50.7M | $48.6M |
| FY2019 | $22.7M | $58.9M | $22.5M |
| FY2020 | $16.2M | $26.5M | $24.7M |
| FY2021 | $22.8M | $45.1M | $42.3M |